Michael A. Pleiss

COMPOSITIONS AND METHODS FOR ANTIGEN-SPECIFIC TOLERANCE

METHOD OF INDUCING ANTIGEN-SPECIFIC TOLERANCE IN A SUBJECT BY ADMINISTERING A COMPOSITION COMPRISING AN APOPTOTIC BODY SURROGATE AND COUPLED IMMUNODOMINANT ANTIGENIC EPITOPES ASSOCIATED WITH AUTOIMMUNE DISEASE

Compositions Comprising Apoptotic Signaling and Methods for Induction of Antigen-Specific Tolerance

Compositions and Methods for Antigen-Specific Tolerance

Substituted benzoxazine and related compounds

Substituted benzoxazine and related compounds

COMPOSITIONS AND METHODS FOR INDUCTION OF ANTIGEN-SPECIFIC TOLERANCE

COMPOSITIONS AND METHODS FOR ANTIGEN-SPECIFIC TOLERANCE

Inhibitors of Protein Kinases

Inhibitors of Protein Kinases

PKC-epsilon inhibitors

PKC-epsilon inhibitors

Multimeric VLA-4 Antagonists Comprising Polymers Moieties

4,6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES

Inhibitors of protein kinases

Multimeric VLA-4 Antagonists Comprising Polymers Moieties

4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases

Multimeric VLA-4 antagonists comprising polymer moieties

ACYLATED AMINO ACID AMIDYL PYRAZOLES AND RELATED COMPOUNDS

Inhibitors of protein kinases

Inhibitors of protein kinases

Inhibitors of protein kinases

Inhibitors of protein kinases

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4

Inhibitors of protein kinases

Methods of treating pain

3-(HETEROARYL)ALANINE DERIVATIVES-INHIBITORS OF LEUKOCYTE ADHESION MEDIATED BY VLA-4

3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4

Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4

Phenylalanine derivatives as alpha 4 integrin inhibitors

Dipeptide and related compounds which inhibit leukocyte adhesion mediated by VLA-4

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

Acylated amino acid amidyl pyrazoles and related compounds

4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-aminocarbonyl)eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases

4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases

Substituted n-phenyl sulfonamide bradykinin antagonists

Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists

Heterocyclic compounds which inhibit leukocyte adhesion mediated by αintegrins

Compounds which inhibit leukocyte adhesion mediated by VLA-4

Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists

4-bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid amide derivatives and related compounds as bradykinin Breceptor antagonists for the treatment of inflammatory diseases

Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4

Novel compounds useful for bradykinin B1 receptor antagonism

Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4

Sulfonylbenzodiazepinone acetamides as bradykinin antagonists

Sulfonylquinoxalone derivatives as bradykinin antagonists

Hydroxyalkanoyl aminopyrazoles and related compounds

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4.

Compounds which inhibit leukocyte adhesion mediated by VLA-4

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds

Heterocyclic compounds which inhibit leukocyte adhesion mediated by αintegrins

Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4

Heteroaryl-β-alanine derivatives as alpha 4 integrin inhibitors

Heterocyclic compounds which inhibit leukocyte adhesion mediated by αintegrins

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

Multimeric VLA-4 antagonists comprising polymer moieties

Succinoyl aminopyrazoles and related compounds

Anti-inflammatory compositions and methods

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds

Pyrimidine hydantoin analogues which inhibit leukocyte adhesion mediated by VLA-4

Compounds which inhibit leukocyte adhesion mediated by VLA-4

Polyethylene glycol conjugates of heterocycloalkyl carboxamido propanoic acids

Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4

Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4

Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

Compounds which inhibit leukocyte adhesion mediated by VLA-4

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

Anti-inflammatory compositions and method

Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

Heteroaryl compounds which inhibit leukocyte adhesion mediated by αintegrins

Compounds which inhibit leukocyte adhesion mediated by VLA-4

Heterocyclic compounds which inhibit leukocyte adhesion mediated by αintegrins

Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4

Alpha amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4

Methods and compositions for treating rheumatoid arthritis

Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents

Methods and compositions for treating rheumatoid arthritis

Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists

Selected substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists

Substituted pyrazole derivatives and related compounds as bradykinin Breceptor antagonists